Table I.

Summary of clinical data for patients with acute pandemic H1N1 virus infections

PatientAgeGenderHAI titerMN titerCo-morbiditiesInitial symptomsHospital courseSample collectionAntiviral treatmentmAb
EM30F6401280noneFever, cough, dyspneaAcute respiratory distress syndrome, bacterial pneumonia, pulmonary embolism, prolonged oscillatory ventilator support, tracheostomy, discharged after 2 moDay 31OseltamivirYes
100037M8040Hypertension, interstitial lung disease of unknown etiologyFever, cough, shortness of breadth, nausea, vomitingPneumonia, acute sinusitis, acute renal failure, discharged after 8 dDay 18Oseltamivir, ZanamavirYes
7038F80160noneFever, cough, body achesN/ADay 15NoneYes
100921M2020Congenital heart disease, repair for Tetralogy of FallotFever, cough, sore throat, nausea, diarrheaN/ADay 9OseltamivirYes
101024M1010noneFever, cough, nausea, vomiting diarrheaN/ADay 11OseltamivirNo
101125M2010noneFever, cough, sore throat, vomiting, headache, confusionN/ADay 9OseltamivirNo
101326M80160noneFever, cough, sore throat, body aches, nausea, vomiting, diarrheaN/ADay 9NoneNo
101445F8020noneFever, chills, cough, sore throat, body aches, headache, nausea, vomitingN/ADay 9NoneNo
  • The mAb column indicates whether mAbs were made from the plasmablasts of these patients.